• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Valeant Pharmaceuticals International

Valeant Pharmaceuticals International

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Valeant Pharma names Eldessouky accounting chief

    Valeant Pharma names Eldessouky accounting chief

  2. UPDATE: U.S. stock futures show S&P stretching for a fresh record

    UPDATE: U.S. stock futures show S&P stretching for a fresh record

  3. MARKET SNAPSHOT: U.S. Stock Futures Indicate S&P 500 Will Stretch For A Fresh Record

    MARKET SNAPSHOT: U.S. Stock Futures Indicate S&P 500 Will Stretch For A Fresh Record

  4. UPDATE: U.S. stock futures indicate S&P 500 will stretch for a fresh record

    UPDATE: U.S. stock futures indicate S&P 500 will stretch for a fresh record

  5. Valeant's stock hit six-year low in active trade; Bill Ackman has yet to make a difference

    Valeant's stock hit six-year low in active trade; Bill Ackman has yet to make a difference

  6. UPDATE: Large Valeant shareholder cuts stake in half, elevating Ackman to largest shareholder

    UPDATE: Large Valeant shareholder cuts stake in half, elevating Ackman to largest shareholder

  7. MARKET SNAPSHOT: S&P 500 Scores Best Finish In More Than 10-months, Fueled By Energy Stocks

    MARKET SNAPSHOT: S&P 500 Scores Best Finish In More Than 10-months, Fueled By Energy Stocks

  8. UPDATE: S&P 500 scores best finish in more than 10-months, fueled by energy stocks

    UPDATE: S&P 500 scores best finish in more than 10-months, fueled by energy stocks

  9. Global Macular Edema Pipeline Report 2016 - Review of 13 Companies & Drug Profiles - Research and Markets

    Global Macular Edema Pipeline Report 2016 - Review of 13 Companies & Drug Profiles - Research and Markets

  10. Jaguar Animal Health Announces $15 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC

    Jaguar Animal Health Announces $15 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.